Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Diversified Consumer Services | Small Cap
Health Score : 6.17Krsnaa Diagnostics Ltd demonstrates a mixed financial performance. The company shows strong solvency and growth, reflected in its high equity ratio and robust growth rates in revenue and operating profit. Profitability metrics such as gross profit margin and return on assets (ROA) are also noteworthy. However, liquidity ratios are poor, indicating potential challenges in meeting short-term obligations. Efficiency ratios are also low, suggesting the company could improve its asset utilization. Furthermore, some financial metrics like adjusted EPS and net margin are concerning, highlighting areas needing attention to ensure sustainable financial health. Overall, Krsnaa Diagnostics exhibits strengths in long-term financial stability and growth, but needs to address its liquidity and efficiency to enhance its competitive positioning in the healthcare services sector. Future performance will depend on addressing these weaknesses and capitalizing on growth opportunities.
Health Score : 6.17Krsnaa Diagnostics Ltd demonstrates a mixed financial performance. The company shows strong solvency and growth, reflected in its high equity ratio and robust growth rates in revenue and operating profit. Profitability metrics such as gross profit margin and return on assets (ROA) are also noteworthy. However, liquidity ratios are poor, indicating potential challenges in meeting short-term obligations. Efficiency ratios are also low, suggesting the company could improve its asset utilization. Furthermore, some financial metrics like adjusted EPS and net margin are concerning, highlighting areas needing attention to ensure sustainable financial health. Overall, Krsnaa Diagnostics exhibits strengths in long-term financial stability and growth, but needs to address its liquidity and efficiency to enhance its competitive positioning in the healthcare services sector. Future performance will depend on addressing these weaknesses and capitalizing on growth opportunities.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
17.69
Industry Median
32.53
Small Cap Median
32.53
P/E RATIO
17.91
P/B RATIO
1.85
Industry Median
3.84
Small Cap Median
3.84
P/S RATIO
2.39
Industry Median
3.46
Small Cap Median
3.46
Others
PEG RATIO
0.00
EV/EBITDA RATIO
7.75
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹559.95 as on Sep 1, 2026.
Growth Score : 8.00The company exhibits strong growth, particularly in revenue and operating profit. This indicates effective business strategies and market positioning. However, the net income growth rate is low, which could be due to various factors such as increased expenses or changes in tax policies. Maintaining a balance between revenue growth and net income growth is crucial for sustainable financial health.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellent
Net Income Growth RatePoor| Growth Ratios | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue Growth Rate | 7.03 | 27.31 | 15.65 | 7.81 |
| Operating Profit Growth Rate | -7.58 | 18.03 | 31.94 | 11.58 |
| Earnings Per Share (EPS) Growth | -9.18 | -11.02 | 36.59 | 30.07 |
| Asset Growth Rate | 3.77 | 28.85 | 9.23 | 42.72 |
| Net Income Growth Rate | -8.82 | -8.06 | 36.84 | 29.49 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medi Assist Healthcare Services Ltd | 8.17 | 28.70 | Neutral | 175.00 | 6.96 | 89.00 |
| 2 | Krsnaa Diagnostics Ltd | 6.17 | 17.91 | Neutral | 212.00 | 31.65 | 101.00 |
| 3 | Suven Life Sciences Ltd | 5.67 | -36.41 | Neutral | -284.00 | -2.08 | -276.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Krsnaa Diagnostics Ltd is a leading Indian diagnostic service provider, offering comprehensive radiology and pathology services. The company primarily operates through public-private partnership (PPP) models, focusing on delivering affordable and accessible diagnostics in non-metro, Tier II, and Tier III cities. It aims to bridge the healthcare gap with a widespread network and advanced technology.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Krsnaa Diagnostics Ltd's P/E ratio (TTM) is 17.69, compared to the industry median of 32.53 and large cap median of 32.53.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Krsnaa Diagnostics Ltd's P/B ratio is 1.85, compared to the industry median of 3.84 and large cap median of 3.84.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Krsnaa Diagnostics Ltd's P/S ratio is 2.39, compared to the industry median of 3.46 and large cap median of 3.46.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Krsnaa Diagnostics Ltd's PEG ratio is 0.75.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Krsnaa Diagnostics Ltd's EV/EBITDA ratio is 7.75.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Krsnaa Diagnostics Ltd's ROE is 10.31%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Krsnaa Diagnostics Ltd's ROA is 11.62%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Krsnaa Diagnostics Ltd's ROCE is 13%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Krsnaa Diagnostics Ltd's operating margin is 27.43%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Krsnaa Diagnostics Ltd's net margin is 13.07%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Krsnaa Diagnostics Ltd's current ratio is 2.49.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Krsnaa Diagnostics Ltd's debt-to-equity ratio is 0.49.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Krsnaa Diagnostics Ltd's interest coverage ratio is 4.82.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Krsnaa Diagnostics Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Krsnaa Diagnostics Ltd's EPS is 30.07.
(Source line: "Ratios as of 24 Oct 2026, based on last traded price of ₹559.95. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2010
Headquarters: Pune, Maharashtra
Core Offerings: Radiology Services, Pathology Services, Tele-radiology, Public-Private Partnership (PPP) Model
Stock Listing: NSE (KRSNAA), BSE (543328)
Promoter: Rajendra Mutha and Family
2010: Incorporated as Krsnaa Diagnostics Private Limited. 2011: Commenced diagnostic operations. 2015: Began operations under the Public-Private Partnership (PPP) model. 2017-2020: Expanded its network rapidly across various states, particularly in Tier II & III cities. 2021: Converted to a public limited company and successfully listed on BSE and NSE through an Initial Public Offering (IPO). Present: Continues its expansion strategy, focusing on affordable and accessible diagnostic services across India.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Radiology Services | Approx. 75% | N/A (consolidated) |
| Pathology Services | Approx. 25% | N/A (consolidated) |
Radiology Services: Offers a comprehensive suite of imaging diagnostics including X-ray, CT Scan, MRI, Ultrasound, Mammography, and PET-CT, utilizing advanced equipment across its network, often through PPP agreements.
Pathology Services: Provides a wide array of laboratory tests covering clinical biochemistry, haematology, microbiology, molecular biology, cytopathology, and histopathology, focusing on timely and accurate results.
Public-Private Partnership (PPP) Model: A significant portion of its operations is conducted through partnerships with state governments, enabling penetration into underserved areas and ensuring affordable access to diagnostic services.
Tele-Radiology: Leverages technology for remote reporting by skilled radiologists, significantly enhancing efficiency and expanding reach, especially to remote and semi-urban locations.
Rajendra Mutha: Managing Director & CEO. He is the founder of Krsnaa Diagnostics and has over 25 years of experience in the diagnostic and healthcare industry, playing a pivotal role in the company's growth and strategic direction.
No major subsidiaries reported.
No major recent corporate actions on record.
The Krsnaa Diagnostics Ltd share price today is ₹559.95 on NSE (KRSNAA), as of 24 Oct 2026.
As of 24 Oct 2026, Krsnaa Diagnostics Ltd share price is ₹559.95, with previous close ₹559.95. Today's range is ₹559.95 to ₹559.95. The 52-week range is ₹493 to ₹775.
As of today, Krsnaa Diagnostics Ltd's market cap is ₹1,847.84 crore (Small Cap).
Krsnaa Diagnostics Ltd's current P/E ratio is 17.69, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 48.
Krsnaa Diagnostics Ltd's current P/B ratio is 1.85.
Krsnaa Diagnostics Ltd's current dividend yield is N/A. Last dividend of ₹0.50 per share was declared on 24-May-2024.
Krsnaa Diagnostics Ltd's EPS (TTM) is ₹30.07.
Krsnaa Diagnostics Ltd is a leading Indian diagnostic service provider, offering comprehensive radiology and pathology services. The company primarily operates through public-private partnership (PPP) models, focusing on delivering affordable and accessible diagnostics in non-metro, Tier II, and Tier III cities. It aims to bridge the healthcare gap with a widespread network and advanced technology.
Krsnaa Diagnostics Ltd is promoted by Rajendra Mutha and Family, holding 27.11% as of 24 Oct 2026.
Krsnaa Diagnostics Ltd is listed on NSE (KRSNAA) and BSE (543328). Its next quarterly results are expected on August 2024.
Cash Earnings Per Share (Cash EPS)
